Skip to content

Simplify Health Care ETF

PINKNYSE ArcaC

$37.79−0.69 (−1.79%)

At close: Oct 13, 2026, 4:00 PM

Intraday session: down, 71 prints from 38.48 to 37.79. Range 37.74 to 38.51. Use the arrow keys to read each point.38.0038.2010 AM12 PM2 PM4 PM
Expense ratio
0.51%
Fund size
$319M
1Y total return
+20.0%
Yield · Last 12 months
0.78%
Holdings
52
Avg volume · 30D
0.1M sh
NAV per share
$38.57
52W range
low $32.03high $40.63
Launched
Filings
SEC EDGAR

The ETF.net PINK Grade

Based on 5 of 6 pillars

C

Score 50 out of 100

Rank
13 of 25
Six-pillar profile for PINK. Scores out of 100: Cost 46, Risk 60, Mission not scored, Tradability 53, Holdings 50, Durability 52. Strongest: Risk (60). Weakest: Cost (46). Based on 5 of 6 pillars.

Score 50 of 100 falls in the C band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.

  • Cost

    The fund’s net expense ratio, ranked against its category.
    C46 out of 100
    Rank 14 of 25
  • Mission

    Whether the fund did what it promised, tested against its stated mandate.
    Not scored
  • Risk

    How the fund held up when markets fell: downside volatility, drawdowns and tail loss.
    B60 out of 100
    Rank 11 of 24
  • Tradability

    How easy the fund is to trade: daily volume, and how far its price strays from net asset value.
    C53 out of 100
    Rank 11 of 25
  • Holdings

    How concentrated the fund is, and how complete and current its disclosed holdings are.
    C50 out of 100
    Rank 17 of 25
  • Durability

    Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.
    C52 out of 100
    Rank 14 of 25

Our read on PINK

ETF.net Research

CMost big health care ETFs just buy the index and sit still. PINK is a stock picker: roughly 60 U.S. names chosen bottom-up, multi-cap, growth-leaning, with room to back companies developing new medicines or cutting system costs.

Stated mandate

PINK seeks long-term capital appreciation through U.S. health care companies, using a multi-cap, fundamental bottom-up approach. It generally follows a growth strategy and may emphasize companies developing medicines or improving health-care-system cost or quality.

Why people hold it

  1. 01Active by design: about 60 U.S. health care names picked bottom-up, not several hundred sorted by market cap. Concentration cuts both ways, but each pick actually matters here.
  2. 02Measured against an all-cap health care benchmark, so small and mid caps are in play, not just the megacap pharma that dominates S&P 500 based sector funds like XLV and RSPH.
  3. 03Charges 0.51%, right at the category median, which is unusual pricing for a hand-picked portfolio rather than an index feed.
  4. 04Sits in the upper half of the broad health care sector group on our review, and pays out quarterly.

Worth knowing

  1. 01The category's index heavyweights (VHT, FHLC, XLV) charge under a tenth of a percent. PINK's fee is roughly six times that, and it buys the manager's judgment.
  2. 02No index to hug. Holdings come from a manager's calls, so the fund can sit far from the health care benchmark in either direction.
  3. 03One sector, one country, about 60 holdings, growth lean. Trial results and health policy headlines land with full force here.

PINK Holdings

As of Oct 13, 2026
Asset class
Stocks
Holdings
52
Top-10 weight
57%
Largest holding
HUM8.1%

Sectors

  • Health Care91.5%
  • Consumer Discretionary4.6%
  • Industrials3.9%

Geography

  • United States96.24%
  • Ireland3.75%
  • France0.01%
The fund’s holdings, weight-ordered — page 1 of 4.
#TickerCompanyWeight %SharesMarket valueIn ETFs
001HUMHumana Inc USD 0.1666678.14%59,733$26M309
002JNJJohnson & Johnson USD 1.07.53%90,822$24M528
003ARQTArcutis Biotherapeutics USD 0.00016.53%792,588$21M99
004UTHRUnited Therapeutics Corp D USD 0.016.36%36,791$20M266
005ABBVAbbVie Inc USD 0.015.20%58,922$17M522
006LLYLilly Eli & Co Npv4.71%12,678$15M583
007WRBYWarby Parker Inc USD 0.00014.70%575,227$15M105
008TMOThermo Fisher Scientific In USD 1.04.61%22,150$15M375
009UNHUnitedHealth Group Inc USD 0.014.47%37,571$14M481
010AVTRAvantor Inc USD 0.014.31%885,669$14M121
011GILDGilead Sciences Inc USD 0.0013.51%74,341$11M492
012PCTPurecycle Technologies I USD 0.00013.45%3,049,835$11M49
013JAZZJazz Pharmaceuticals PLC USD 0.00013.36%49,320$11M212
014DGXQuest Diag Com USD0.013.32%45,428$11M302
015BNTCBenitec Biopharma Inc Npv3.11%1,092,056$10M32

Showing 1–15 of 52 holdings

PINK Performance

Launched Oct 7, 2021

Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.

Not enough history yet.
PINK$11,999
SPY tracks large US stocks. It provides market context, rather than representing this fund’s strategy, asset class or investment benchmark.$12,044
Oct 10, 2025 to Oct 12, 2026. PINK $11,999. SPY $12,044. Use the arrow keys to read each point.$9,541$11,170$12,799Oct 2025Apr 2026Oct 2026

Oct 10, 2025 – Oct 12, 2026

Returns run to the Oct 12, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.

Trailing total return for PINK. Periods over one year show the average yearly return.
PeriodPINK
Year to date+5.7%
1 month−0.3%
3 months−2.6%
1 year+20.0%
3 yearsper year+16.6%
5 yearsper year+9.8%
10 yearsFund is under 10 years oldper year—

As of the close, with distributions reinvested.

Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.

Annual total returns for PINK
YearReturn barPINK
2026 YTD+5.7%
2025+24.4%
2024+8.8%
2023+3.8%
2022−4.4%
2021+12.2%

History from Oct 8, 2021

PINK in the news

Filtered to PINK · Health Care (Broad)

PINK Dividends

Adds up every distribution paid per share over the last 12 months, divided by the last completed close. Distributions are counted by ex-date. Data through Oct 12, 2026.
0.78%Last 12 months
Payout per share
$0.30Last 12 months
Last payment
$0.10 per share
Paid on
Shares bought on or after this date do not qualify for this distribution.
Frequency
Quarterly

Distribution history

2021–2026

One bar per payment. 20 payments from 2021 to 2026 YTD. Dec 27, 2021 $0.01; Mar 28, 2022 $0.04; Jun 27, 2022 $0.03; Sep 27, 2022 $0.03; Dec 27, 2022 $0.02; Mar 27, 2023 $0.02; Jun 27, 2023 $0.13; Sep 27, 2023 $0.03; Dec 26, 2023 $0.08; Mar 25, 2024 $0.03; Jun 25, 2024 $0.03; Sep 25, 2024 $0.02; Dec 23, 2024 $0.01; Mar 26, 2025 $0.05; Jun 25, 2025 $0.05; Sep 25, 2025 $0.05; Dec 23, 2025 $0.10; Mar 26, 2026 $0.05; Jun 25, 2026 $0.05; Sep 25, 2026 $0.10. Use the arrow keys to read each point.202120222023202420252026YTD
Ex-datePay dateAmount per share
Sep 25, 2026Sep 30, 2026$0.10
Jun 25, 2026Jun 30, 2026$0.05
Mar 26, 2026Mar 31, 2026$0.05
Dec 23, 2025Dec 31, 2025$0.10
Sep 25, 2025Sep 30, 2025$0.05
Jun 25, 2025Jun 30, 2025$0.05
Mar 26, 2025Mar 31, 2025$0.05
Dec 23, 2024Dec 31, 2024$0.01
Sep 25, 2024Sep 30, 2024$0.02
Jun 25, 2024Jun 28, 2024$0.03
Mar 25, 2024Mar 28, 2024$0.03
Dec 26, 2023Dec 29, 2023$0.08

PINK Risk

How much the fund’s monthly returns vary, scaled to a year.
16.4%
Annualised · 36 months to Sep 2026
How it’s calculated: standard deviation

The sample standard deviation of monthly total returns, multiplied by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.

Return above 3-month US Treasury bills per unit of volatility.
0.72
vs 3-month T-bills · to Sep 2026
How it’s calculated: Sharpe ratio

Subtract each month’s Treasury-bill return from the fund’s monthly total return.

Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.

Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.

The largest fall from a peak to the low that followed.
−18.8%
Trough Apr 2025
How it’s calculated: maximum drawdown

The largest percentage decline from an earlier peak, using total returns with reinvested distributions.

Uses up to five years through the last close, with at least 12 months required.

How strongly the fund’s returns move with its asset-class index.
0.73
vs its asset-class index
How it’s calculated: beta

The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.

PINK Cost

Expense ratio0.51%
  • The middle half of Health Care (Broad) funds
  • Median 0.50%

13 of the 25 Health Care (Broad) funds charge less.

PINK costs $51.00 a year on $10,000. The median Health Care (Broad) fund costs $50.00.

Other funds in Health Care (Broad)